美国 FDA 批准 Elanco 公司治疗犬寄生虫感染的药物

Reuters
08 Oct 2024

((自动化翻译由路透提供,请见免责声明 ))

路透10月7日 - 美国食品和药物管理局已批准了Elanco Animal Health公司 的口服药物,用于保护狗免受六种寄生虫感染。

该公司称,这种名为Credelio Quattro的药物是一种每月一次的咀嚼片,适用于8周龄或8周龄以上的狗。

该药被批准用于治疗跳蚤和蜱虫感染,以及蛔虫、钩虫和绦虫感染。它还被批准用于预防狗的跳蚤侵扰和心丝虫病。

该公司预计在 2025 年第一季度推出这种药物。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10